RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

Currency in GBP	2025
Operating Income	3.03 Billion
Income Before Tax	2.75 Billion
Income Tax Expense	672.00 Million
Net Income	2.06 Billion
Eps	1.13
Epsdiluted	1.12
Weighted Average Shs Out	1.83 Billion
Weighted Average Shs Out Dil	1.84 Billion
Research And Development Expenses	N/A
Selling General And Administrative Expenses	N/A
Depreciation And Amortization	752.00 Million
Interest Expense	298.00 Million
Interest Income	12.00 Million
Net Interest Income	-258 Million
Premiums Earned	N/A
Policyholder Benefits	N/A
Gross Profit	6.36 Billion
Ebitda	3.78 Billion
Source	edgar-ifrs
Ebit	3.02 Billion

RELX PLC Annual Reports (10-K)